Is Abbott Laboratories Stock a Good Investment?
Abbott Laboratories Investment Advice | ABT |
- Examine Abbott Laboratories' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Abbott Laboratories' leadership team and their track record. Good management can help Abbott Laboratories navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Abbott Laboratories' business and its evolving consumer preferences.
- Compare Abbott Laboratories' performance and market position to its competitors. Analyze how Abbott Laboratories is positioned in terms of product offerings, innovation, and market share.
- Check if Abbott Laboratories pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Abbott Laboratories' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Abbott Laboratories stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Abbott Laboratories is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Abbott Laboratories Stock
Researching Abbott Laboratories' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 77.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.23. Abbott Laboratories last dividend was issued on the 15th of October 2024. The entity had 10000:4798 split on the 2nd of January 2013.
To determine if Abbott Laboratories is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Abbott Laboratories' research are outlined below:
| Abbott Laboratories generated a negative expected return over the last 90 days | |
| Abbott Laboratories has a strong financial position based on the latest SEC filings | |
| Over 77.0% of the company shares are held by institutions such as insurance companies | |
| On 15th of November 2024 Abbott Laboratories paid $ 0.55 per share dividend to its current shareholders | |
| Latest headline from businesswire.com: Nutraceuticals Market Report 2024, with Profiles of Abbott, Ajinomoto, Beneo, Cargill, Danone, DSM-Firmenich, Herbalife, Hildur Functional Foods, International Flavors Fragrances, Nestle Novozymes - ResearchAndMarkets.com |
Abbott Laboratories Quarterly Liabilities And Stockholders Equity |
|
Abbott Laboratories uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Abbott Laboratories. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Abbott Laboratories' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 17th of April 2024 Upcoming Quarterly Report | View | |
| 18th of July 2024 Next Financial Report | View | |
| 31st of March 2024 Next Fiscal Quarter End | View | |
| 22nd of January 2025 Next Fiscal Year End | View | |
| 31st of December 2023 Last Quarter Report | View | |
| 31st of December 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact Abbott Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Abbott Laboratories' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2017-04-19 | 2017-03-31 | 0.43 | 0.48 | 0.05 | 11 | ||
2015-04-22 | 2015-03-31 | 0.42 | 0.47 | 0.05 | 11 | ||
2014-04-16 | 2014-03-31 | 0.36 | 0.41 | 0.05 | 13 | ||
2020-04-16 | 2020-03-31 | 0.58 | 0.65 | 0.07 | 12 | ||
2023-01-25 | 2022-12-31 | 0.92 | 1.03 | 0.11 | 11 | ||
2021-07-22 | 2021-06-30 | 1.02 | 1.17 | 0.15 | 14 | ||
2020-07-16 | 2020-06-30 | 0.42 | 0.57 | 0.15 | 35 | ||
2022-10-19 | 2022-09-30 | 0.94 | 1.15 | 0.21 | 22 |
Know Abbott Laboratories' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Abbott Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Abbott Laboratories backward and forwards among themselves. Abbott Laboratories' institutional investor refers to the entity that pools money to purchase Abbott Laboratories' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Wells Fargo & Co | 2024-09-30 | 17 M | Legal & General Group Plc | 2024-09-30 | 14.3 M | Polen Capital | 2024-09-30 | 13.9 M | State Farm Mutual Automobile Ins Co | 2024-09-30 | 13.6 M | Bank Of New York Mellon Corp | 2024-09-30 | 13.6 M | Massachusetts Financial Services Company | 2024-09-30 | 13.3 M | Charles Schwab Investment Management Inc | 2024-09-30 | 12.6 M | Ameriprise Financial Inc | 2024-09-30 | 12.1 M | Deutsche Bank Ag | 2024-09-30 | 11.5 M | Vanguard Group Inc | 2024-09-30 | 167.9 M | Blackrock Inc | 2024-06-30 | 131.1 M |
Abbott Laboratories' market capitalization trends
The company currently falls under 'Mega-Cap' category with a total capitalization of 200.33 B.Market Cap |
|
Abbott Laboratories' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.14 | 0.17 | |
| Return On Capital Employed | 0.11 | 0.10 | |
| Return On Assets | 0.08 | 0.12 | |
| Return On Equity | 0.15 | 0.26 |
Determining Abbott Laboratories' profitability involves analyzing its financial statements and using various financial metrics to determine if Abbott Laboratories is a good buy. For example, gross profit margin measures Abbott Laboratories' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Abbott Laboratories' profitability and make more informed investment decisions.
Abbott Laboratories' Earnings Breakdown by Geography
Please note, the imprecision that can be found in Abbott Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Abbott Laboratories. Check Abbott Laboratories' Beneish M Score to see the likelihood of Abbott Laboratories' management manipulating its earnings.
Evaluate Abbott Laboratories' management efficiency
Abbott Laboratories has Return on Asset of 0.0649 % which means that on every $100 spent on assets, it made $0.0649 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1484 %, implying that it generated $0.1484 on every 100 dollars invested. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Abbott Laboratories' Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.12 in 2024, whereas Return On Capital Employed is likely to drop 0.10 in 2024. At this time, Abbott Laboratories' Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 44.7 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 8.3 B in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 22.39 | 23.51 | |
| Tangible Book Value Per Share | 3.65 | 3.83 | |
| Enterprise Value Over EBITDA | 18.84 | 19.79 | |
| Price Book Value Ratio | 4.94 | 2.62 | |
| Enterprise Value Multiple | 18.84 | 19.79 | |
| Price Fair Value | 4.94 | 2.62 | |
| Enterprise Value | 179.9 B | 188.9 B |
Abbott Laboratories' management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Dividend Yield 0.0191 | Forward Dividend Yield 0.0191 | Forward Dividend Rate 2.2 | Beta 0.722 |
Basic technical analysis of Abbott Stock
As of the 11th of December 2024, Abbott Laboratories shows the mean deviation of 0.7665, and Risk Adjusted Performance of 0.0035. Abbott Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Abbott Laboratories' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Abbott Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Abbott Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Abbott Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mccoy John A. Jr. over three months ago Disposition of tradable shares by Mccoy John A. Jr. of Abbott Laboratories at 113.27 subject to Rule 16b-3 | ||
Robert Alpern over three months ago Acquisition by Robert Alpern of tradable shares of Abbott Laboratories subject to Rule 16b-3 |
Abbott Laboratories' Outstanding Corporate Bonds
Abbott Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Abbott Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Abbott bonds can be classified according to their maturity, which is the date when Abbott Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| ABBOTT LABS 295 Corp BondUS002824BB55 | View | |
| ABBOTT LABS 6 Corp BondUS002824AV29 | View | |
| ABBOTT LABS 53 Corp BondUS002824AY67 | View | |
| US002824BP42 Corp BondUS002824BP42 | View | |
| US002824BQ25 Corp BondUS002824BQ25 | View |
Understand Abbott Laboratories' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Abbott Laboratories' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0035 | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 0.7665 | |||
| Semi Deviation | 0.9541 | |||
| Downside Deviation | 0.9687 | |||
| Coefficient Of Variation | 217213.41 | |||
| Standard Deviation | 1.06 | |||
| Variance | 1.12 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | (0.13) | |||
| Treynor Ratio | (0.03) | |||
| Maximum Drawdown | 6.26 | |||
| Value At Risk | (1.65) | |||
| Potential Upside | 1.27 | |||
| Downside Variance | 0.9384 | |||
| Semi Variance | 0.9103 | |||
| Expected Short fall | (0.82) | |||
| Skewness | 0.9108 | |||
| Kurtosis | 4.82 |
| Risk Adjusted Performance | 0.0035 | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 0.7665 | |||
| Semi Deviation | 0.9541 | |||
| Downside Deviation | 0.9687 | |||
| Coefficient Of Variation | 217213.41 | |||
| Standard Deviation | 1.06 | |||
| Variance | 1.12 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | (0.13) | |||
| Treynor Ratio | (0.03) | |||
| Maximum Drawdown | 6.26 | |||
| Value At Risk | (1.65) | |||
| Potential Upside | 1.27 | |||
| Downside Variance | 0.9384 | |||
| Semi Variance | 0.9103 | |||
| Expected Short fall | (0.82) | |||
| Skewness | 0.9108 | |||
| Kurtosis | 4.82 |
Consider Abbott Laboratories' intraday indicators
Abbott Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Abbott Laboratories stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 74171.17 | |||
| Daily Balance Of Power | 0.283 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 115.33 | |||
| Day Typical Price | 115.39 | |||
| Price Action Indicator | 0.47 | |||
| Period Momentum Indicator | 0.6 |
Abbott Laboratories Corporate Filings
8K | 15th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 31st of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 23rd of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 25th of June 2024 Other Reports | ViewVerify |
Abbott Stock media impact
Far too much social signal, news, headlines, and media speculation about Abbott Laboratories that are available to investors today. That information is available publicly through Abbott media outlets and privately through word of mouth or via Abbott internal channels. However, regardless of the origin, that massive amount of Abbott data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Abbott Laboratories news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Abbott Laboratories relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Abbott Laboratories' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Abbott Laboratories alpha.
Abbott Laboratories Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Abbott Laboratories can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Abbott Laboratories Historical Investor Sentiment
Investor biases related to Abbott Laboratories' public news can be used to forecast risks associated with an investment in Abbott. The trend in average sentiment can be used to explain how an investor holding Abbott can time the market purely based on public headlines and social activities around Abbott Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Abbott Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abbott Laboratories and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Abbott Laboratories news discussions. The higher the estimate score, the more favorable the investor's outlook on Abbott Laboratories.
Abbott Laboratories Corporate Directors
| Samuel Scott | Independent Director | Profile | |
| Phebe Novakovic | Independent Director | Profile | |
| Roxanne Austin | Independent Director | Profile | |
| Sally Blount | Independent Director | Profile |
Already Invested in Abbott Laboratories?
The danger of trading Abbott Laboratories is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Abbott Laboratories is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Abbott Laboratories. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Abbott Laboratories is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.